The study on efficacy of Rituximab in new onset Type 1 diabetes mellitus
Not Applicable
Recruiting
- Conditions
- Type 1 diabetes mellitus
- Registration Number
- JPRN-UMIN000013622
- Lead Sponsor
- niversity of Occupational and Environmental Health, Japan, First Department of Internal Medicine, School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
Patients using insulin therapy, those who were or may have been pregnant, and those with severe liver dysfunction (AST and ALT: 3 times the normal levels) were excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The rate of change of curve undersurface area of the serum C peptide concentration in the meal load examination 12 months after rituximab administration.
- Secondary Outcome Measures
Name Time Method